Skip to main content
SpringerLink
Log in

Surgery of the Adrenals

  • Chapter
Manual of Endocrine Surgery

Part of the book series: Comprehensive Manuals of Surgical Specialties ((CMSS))

Abstract

The adrenal gland comprises two physiologically and embryologically distinct parts: the cortex and medulla. It produces a wide variety of hormones whose synthesis, secretion, regulation, and end effects are highly complex. Rather dramatic physical changes and symptoms may result from hormonal imbalance.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Weinberger MA: Pheochromocytoma. Arch Intern Med 112: 677, 1963.

    PubMed  CAS  Google Scholar 

  2. Manger WM, Gifford RW Jr: Current concepts of pheochromocytoma.Cardiovasc Med 3: 289–309, 1978.

    Google Scholar 

  3. Manger W. Gifford RW Jr: Pheochromocytoma. New York, Springer-Verlag, 1977.

    Google Scholar 

  4. Lightman S: Adrenal medulla.InJames VHT (ed): Comprehensive Endocrinology, The Adrenal Gland. New York, Raven Press, 1979, p 296.

    Google Scholar 

  5. Gitlow SE, Mendlowitz M, Bestani LM: The biochemical techniques for detecting and establishing the presence of a pheochromocytoma. Am J Cardiol 26: 270–279, 1970.

    PubMed  CAS  Google Scholar 

  6. ReMine WH, Chong GC, van Heerden JA, et al: Current management of pheochromocytoma. Ann Surg 179: 740–747, 1974.

    PubMed  CAS  Google Scholar 

  7. van Heerden JA, Sheps SG, Hamberger B, ReMine WH, et al: Pheochromocytoma: current status and changing trends. Surg 91: 367–373, 1982.

    Google Scholar 

  8. Scott HW Jr, Oates JA, Nies AS, et al: Pheochromocytoma: present diagnosis and management. Ann Surg 183: 587–593, 1976.

    PubMed  Google Scholar 

  9. St John Sutton MG, Sheps SG, Lie JT: Prevalence of clinically unsuspected pheochromocytoma: review of a 50-Year Autopsy Series. Mayo Clin Proc 56: 354–360, 1981.

    Google Scholar 

  10. Hume DM: Pheochromocytoma in the adult and in the child. Am J Surg 99: 458–496, 1960.

    PubMed  CAS  Google Scholar 

  11. Mayo CH: Paroxysmal hypertension with tumor of retroperitoneal nerve: report of case. JAMA 89: 1047–1050, 1927.

    Google Scholar 

  12. Graham JV: Collective review: pheochromocytoma and hypertension: an analysis of 207 cases. Int Abstr Surg 92: 105–121, 1951.

    PubMed  CAS  Google Scholar 

  13. Stackpole RH, Melicow MM, Uson AC: Pheochromocytoma in childhood. J Pediatr 63: 315–330, 1963.

    Google Scholar 

  14. Javadpour N, Woltering EA, Brennan MF: Adrenal neoplasms. Curr Probl Surg, 17: 5–52, 1980.

    Google Scholar 

  15. Van Way CW III, Scott HW Jr, Page DL, etal: Pheochromocytoma. Curr Probl Surg, June, 1974, p 1–59.

    Google Scholar 

  16. Scott HW Jr, Reynolds V, Green N, etal: Clinical experience with malignant pheochromocytomas. Surg Gynecol Obstet 154: 801–818, 1982.

    PubMed  Google Scholar 

  17. Melicow MM: One hundred cases of pheochromocytoma (107 tumors) at the Columbia-Presbyterian Medical Center, 1926-76: a clinic’s pathologic analysis. Cancer 40: 1987–2004, 1977.

    PubMed  CAS  Google Scholar 

  18. Thompson N: Personal communication, 1983.

    Google Scholar 

  19. Croat JR, Sjoerdsma A: Turnover and metabolism of catecholamines in patients with pheochromocytoma. J Clin Invest 43: 94–102, 1964.

    Google Scholar 

  20. Gifford RW, Kuale WF, Maker FT, etal: Clinical features, diagnosis and treatment of pheochromocytoma: a review of 76 cases. Mayo Clin Proc 39: 280–302, 1964.

    Google Scholar 

  21. Modlin IM, Famdon JR, Shepherd A, etal: Pheochromocytomas in 72 patients: clinical and diagnostic features, treatment and long-term results. Br J Surg 66: 456–465, 1979.

    PubMed  CAS  Google Scholar 

  22. Glushien AJ, Mansuy MM, Littman DS: Pheochromocytoma: the relationship to the neurocutaneous syndromes. Am J Med 14: 318–327,1953.

    PubMed  CAS  Google Scholar 

  23. Weichert RF: The neural ectodermal origin of the peptide-secreting endocrine glands: a unifying concept for the etiology of multiple endocrine adenomatosis and the inappropriate secretion of peptide hormones by nonendocrine tumors. Am J Med 29: 232–241, 1970.

    Google Scholar 

  24. Rosati LA, Augua NA: Ischemic enterocolitis in pheochromocytoma. Gastroenterology 60: 581–585, 1971.

    PubMed  CAS  Google Scholar 

  25. Scharf Y,Nahir M.Plavoic Y, etal: Intermittent claudication with pheochromocytoma. JAMA 205:547, 1968.

    Google Scholar 

  26. Gitlow SE, Pertsemlidis D.Bertani LM: Management of patients with pheochromocytoma. Am Heart J 82: 557–567, 1971.

    PubMed  CAS  Google Scholar 

  27. Harrison TS, Seton JF,Munion GL:High-performance liquid chromatography for urinary catecholamine determination in patients taking alpha-methydopa. World J Surg 5: 462, 1981.

    Google Scholar 

  28. Bravo EL, Taragi RC. Gifford RW, etal: Circulating and urinary catecholamine in pheochromocytoma: diagnostic and implications.N Engl J Med 301: 682–686, 1979.

    PubMed  CAS  Google Scholar 

  29. Hamberger B. Arver S. Eskilsson P, etal: Plasma catecholamine levels in the diagnosis and management of. Surg Gynecol Obstet 152: 291–296, 1981.

    PubMed  CAS  Google Scholar 

  30. Kopin IJ(moderator): Plasma levels of norepinephrine.Ann Intern Med 88:67l–680, 1978.

    PubMed  CAS  Google Scholar 

  31. Engelman K, Hammmond NG: Adrenalin production by an intrathoracic pheochromocytoma. Lancet l: 609–611, 1968.

    PubMed  CAS  Google Scholar 

  32. Mannix BJr. U’Grady WP. Ghlow SL: Extra-adrenal pheochromocytoma producing epinephrine. Arch Surg 104: 216, 1972.

    PubMed  Google Scholar 

  33. Hattery RR, Sheedy PF, Stephens DH, etal: Computed tomography of the adrenal gland. Semin Roentgenol 16: 290–300, 1981.

    PubMed  CAS  Google Scholar 

  34. Stewart BH, Bravo EL, Haager J, etal: Localization of pheochromocytoma by computed tomograpby. N Engl J Med 299: 460–461, 1978.

    PubMed  CAS  Google Scholar 

  35. Thomas JL, Bernardino ME, Samaan NA,etal: CT of Pheochromocytoma.Am J Roentgenol 135: 477–482, 1980.

    CAS  Google Scholar 

  36. Sisson JC, Frager MS, Valk TS, etal: Scintigraphic localization of pheochromocytoma. N Engl J Med 305: 12–17, 1981.

    PubMed  CAS  Google Scholar 

  37. Valk TW, Frager MS, Gross MD, etal: Spectrum of pheochromocytoma in multiple endocrine neoplasiu. Ann Intern Med 94: 762–787, 1981.

    PubMed  CAS  Google Scholar 

  38. Sutton H. Wyetb P, Allen AO, etal: Disseminated malignant pheochromocytoma: localization with iodine- 131-labelled beta- Iodobenzylguanidine. Br Med J 285: 1153–1154, 1902.

    Google Scholar 

  39. Brogden RN, Heel RC, Speight TM, etal: Alpha- methyl-p-tyrosine: a review of its pharmacology and its clinical use. Drugs 2:81, 1981.

    Google Scholar 

  40. Goldfien A: Pheochromocytoma: diagnosis and anesthetic and surgical management.Anesthesiology 24:462–47l, 1963.

    PubMed  CAS  Google Scholar 

  41. Kreul JF, Dauchot PJ, Anton AH: Hemodynamic and catecholamine studies during pheochromocytoma resection under enflurane anesthesia. Anaesthesiology 44: 265–200, 1976.

    CAS  Google Scholar 

  42. Johns VJ, Brunjes S: Pheochromocytoma. Am J Cardiol 9: 120–125, 1962.

    PubMed  Google Scholar 

  43. Scott W. Dean RH, Lea JW, etal: Surgical experience with retrogastric and retropancreatic pheochromocytomas. Surgery 92: 853–865, 1982.

    PubMed  Google Scholar 

  44. Sellwood RA, Wapnick S, Breckenridge A, etal: Recurrent pheochromocytoma. Br J Surg 57: 309–312, 1970.

    PubMed  CAS  Google Scholar 

  45. Beierwaltes WH: New horizons for therapeutic nuclear medicine in 1981. J Nucl Med 22:549–554. 1981.

    PubMed  CAS  Google Scholar 

  46. James RE, Baker HL, Scanlon PW: The roentgenologic aspects of metastatic pheochromocytoma. Am J Roentgenol Radium Ther Nucl Medl 115:783–793,l972.

    CAS  Google Scholar 

  47. Fudge TL, McKinnon WMP, Geary NL: Current surgical management of pheochromocytoma during pregnancy. Arch Surg 115: 1224, 1980.

    PubMed  CAS  Google Scholar 

  48. Schenker JG, Chowers I: Pheochromocytoma and pregnancy. Obstet Gynecol Surv 26: 739–747, 1971.

    PubMed  CAS  Google Scholar 

  49. Freier DT, Eckhauser FE, Harisson TS: Phechromocytoma: apersistently problematic and still potentially lethal disease. Arch Surg 115; 388–391. 1980.

    PubMed  CAS  Google Scholar 

  50. Harrison TS,Thompson NW: Multiple endocrine adenomatosis.Curr Probl Surg, August, 1975.

    Google Scholar 

  51. Sizemore GW, Heath H III, Carney JA: Multiple endocrine neoplasia type 2. Clin Endocrinol Metab 9: 299–315, 1980.

    PubMed  CAS  Google Scholar 

  52. Webb TA, Sheps SG, CarneyJA: Differences between sporadic pheochromocytoma in multiple endocrine neoplasia, type 2. Am J Surg Pathol 4: 121–126, 1980.

    PubMed  CAS  Google Scholar 

  53. van Heerden JA, Sizemore GW, Carney YA, etal: Surgical management of the adrenal glands in the multiple endocrine neoplasia type 2 syndrome. In Press.

    Google Scholar 

  54. Freier DT, Thompson NW,Sisson JC, etal: Dilemmas in the early diagnosis and treatment of multiple endocrine adenomatosis, type 11. Surgery 82: 407–413, 1977.

    PubMed  CAS  Google Scholar 

  55. Fishman LM, Juchel O,Liddle GW. etal: Incidence of primary aldosteronism in uncomplicated “essential” hypertension. JAMA. 205: 497–502, 1968.

    PubMed  CAS  Google Scholar 

  56. Laragh JH, Sealey JE, Sommers SC: Patterns of adrenal secretion and urinary excretion of aldosterone and plasma renin activity in normal and hypertensive subjects. Circ Res [Suppl I] 18, 19:I-158-I-174. 1966.

    Google Scholar 

  57. Streeten DHP,Touryz N, Anderson GH: Reliability of screening methods for the diagnosis of primary aldosteronism. Am J Med 67: 403–413, 1979.

    PubMed  CAS  Google Scholar 

  58. Giebink ES, Gotlin RW, Biglieri EG, etal: A kindred with familial glucocorticoid suppressible aldosteronism. J Clin Endocrinol Metab 36: 715–723, 1973.

    PubMed  CAS  Google Scholar 

  59. Sutherland DJA, Ruse JL, Laidlaw JC: Hypertension, increased aldosterone secretion, and low plasma renin activity relieved by dexamethasone. Can Med Assoc J 95: 1109–1119, 1966.

    PubMed  CAS  Google Scholar 

  60. Auda SP,Brennan MF, Gill JR: Evolution of the surgical management of primary aldosteronism.Ann Surg 191: 1–7, 1980.

    PubMed  CAS  Google Scholar 

  61. Grant CS, Carpenter P, Hamberger B, etal: The management of primary aldosteronism. Arch Surg 119: 585–590, 1984.

    PubMed  CAS  Google Scholar 

  62. Hunt TK, Schambelan M, Biglieri EG: Selection of patients and operative approach in primary aldosteronism. Ann Surg 182:353–361, 1975.

    PubMed  CAS  Google Scholar 

  63. Neville AM: The nodular adrenal. Invest Cell Pathol 1:99–11, 1978.

    PubMed  CAS  Google Scholar 

  64. Kaplan NM: The steroid content of adrenal adenomas and measurements of aldosterone production in patients with essential hypertension and primary,aldosteronism. J Clin Invest 46: 728–734, 1967.

    PubMed  CAS  Google Scholar 

  65. Ferriss JB, Beevers DG, Brown JJ, etal: Clinical, biochemical, and pathological features of low-renin (“Primary”) hyperalddosterooism. Am Heart J 95:375–388, 1978.

    PubMed  CAS  Google Scholar 

  66. Mackett MCT, Crane MG, Smith LL: Surgical management of aldosterone-producing adrenal adenomas. Am J Surg 142:89–95, 1981.

    PubMed  CAS  Google Scholar 

  67. Beevers DG,Brown JJ, Ferris JR, etal: Renal abnormalities and vascular complications in primary aldosteronism. Evidence on tertiary hyperaldosteronism Q J Med 45: 401–410, 1976.

    Google Scholar 

  68. Conn JW: Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45: 3–17, 1955.

    PubMed  CAS  Google Scholar 

  69. Delarue NC, Laidlaw JC, Kovacsk K, etal: Hypertension due to “primary” aldosteronism-surgical considerations. Surgery 80: 289–296, 1976.

    Google Scholar 

  70. Weinberger MH, Grim CE, Hollifield JW, etal: Primary aldosteronism. Ann Intern Med 90: 386–395, 1979.

    PubMed  CAS  Google Scholar 

  71. Hiramatsu K. Yamada T, Yukimura Y, etal: A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Arch Intern Med 141: 1509–1593, 1981.

    Google Scholar 

  72. Melby JC, Spark R, Cale S, etal: Diagnosis and localization of aldosterone-producing adenomas by adrenal vein catheterization. N Engl J Med 277: 1050–1056, 1967.

    PubMed  CAS  Google Scholar 

  73. Granberg PO, Adamson U. Cohn KH, etal: The management of patients with primary aldosteronism. World J Surg 6: 757–764, 1982.

    PubMed  CAS  Google Scholar 

  74. Melby JC: Assessment of adrenocortical function. N Engl J Med 285: 735–739, 1971.

    PubMed  CAS  Google Scholar 

  75. Conn JW, Rovner DR, Cohen EC, etal: Preoperative diagnosis of primary aldosteronism. Arch Intern Med 123: 113–123, 1969.

    PubMed  CAS  Google Scholar 

  76. St. Cyr MJ, Sancho JM, Melby JC: Quantitation of plasma aldosterone by radio-immunoassay. Clin Chem 18: 1395, 1972.

    PubMed  CAS  Google Scholar 

  77. Ganguly A, Melada GA, Luetsoher JA, etal: Control of plasma aldosterone in primary aldosteronism: distinction between adenoma and hyperplasia. J Clin Endocrinol Metab 37: 765–775, 1973.

    PubMed  CAS  Google Scholar 

  78. Herf SM, Teates DC, Tegtmeyer CJ, etal: Identification and differentiation of surgically correctable hypertension due to primary aldosteronism. Am J Med 67: 397–402, 1979.

    PubMed  CAS  Google Scholar 

  79. Vaughan NJA, Jowett TP, Slater JDH, etal: The diagnosis of primary hyperaldosteronism. Lancet, 1: 120–125, 1981.

    PubMed  CAS  Google Scholar 

  80. Wisgerhof M, Brown RD, Hogan JJ, etal: The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism. J Clin Endocrinol Metab 52: 195–198, 1981.

    PubMed  CAS  Google Scholar 

  81. Edis AJ: In Discussion of Herwig KR: Primary aldosteronism: experience with thirty-eight patients. Surgery 86: 470–74, 1979.

    Google Scholar 

  82. Eghrari M, McLoughlin JJ, Roses IE, etal: The role of computed tomography in assessment of tumor pathology of the adrenal glands. J Comput Assist Tomogr 4: 71, 1980.

    PubMed  CAS  Google Scholar 

  83. Montagne J, Kressel JY, Korabkin M, etal: Computed tomography of the normal adrenal glands. Am J Roentgenol 130: 963–6, 1978.

    CAS  Google Scholar 

  84. White EA, Schambelan M, Rost CR, etal: Use of computed tomography in diagnosing the cause of primary aldosteronism. N EngI J Med 303: 1503–1507, 1980.

    CAS  Google Scholar 

  85. Gross MD, Greitas JE, Grekin RJ, etal: Letter. N Engl J Med 304: 1046, 1981.

    Google Scholar 

  86. Miles JM, Wahner HW, Carpenter PC, etal: Adrenal scintiscanning with NP-59: a new radioiodinated cholesterol agent. Mayo Clin Proc 54: 321–327, 1979.

    PubMed  CAS  Google Scholar 

  87. Herwig KR: Primary aldosteronism: experience with thirty-eight patients. Surgery, 86: 470–74, 1979.

    PubMed  CAS  Google Scholar 

  88. Adamson U, Efendie S, Granberg PO, etal: Preoperative localization of aldostesrone-producing adenomas. An analysis of the efficacy of different diagnostic procedures made from 11 cases and from a review of the literature. Acta Med Stand 208: 101–109, 1980.

    CAS  Google Scholar 

  89. Davis WW, Newsome HH, Wright LD, etal: Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia, and suppressed renin activity. Am J Med 42: 642–647, 1967.

    PubMed  CAS  Google Scholar 

  90. Scoggins BA, Coghlan JJ: Primary hyperaldosteronism. Pharmacol Ther 9: 367–394, 1980.

    PubMed  CAS  Google Scholar 

  91. Kremer D, Boddy K, Brown JJ, etal: Amiloride in the treatment of primary hyperaldosteronism and essential hypertension. Clin Endocrinol 7: 151–157, 1977.

    CAS  Google Scholar 

  92. Russell CF, Hamberger B, van Heerden JA, etal: Adrenalectomy: Anterior or posterior approach. Am J Surg 144: 322–324, 1982.

    PubMed  CAS  Google Scholar 

  93. Cushing H: The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 50: 137–195, 1932.

    Google Scholar 

  94. Plotz CM, Knowlton AL, Ragan C: Natural history of Cushing’ syndrome. Am J Med 13: 597–614, 1952.

    PubMed  CAS  Google Scholar 

  95. Welbourn RB, Montgomery DAD, Kennedy TL: The natural history of treated Cushing’;s syndrome. Br J Surg 58: 1–16, 1971.

    PubMed  CAS  Google Scholar 

  96. Frajria R, Angeli A: Alcohol-induced pseudo-Cushing’;s syndrome. Lancet 1: 1050–1051, 1977.

    PubMed  CAS  Google Scholar 

  97. Rees LH, Besser GM, Jeffcoate WJ, etal: Alcohol-induced pseudo-Cushing’;s syndrome. Lancet 1:726–720. 1977.

    PubMed  CAS  Google Scholar 

  98. Thompson NW; Allo MD; Management of acute hypercortisolism. World J Surg 6:748–756, 1982.

    PubMed  CAS  Google Scholar 

  99. Orth DN, Liddle GW: Results of treatment in 108 patients with Cusbing’s syndrome. N Engl J Med 285:243–247, 1971.

    PubMed  CAS  Google Scholar 

  100. Thompson JA, Whyte WG, Stirling WB: The treatment of Cushing’s syndrome by subtotal adrenalectomy.InBinder C,Hall PE (eds): Cushing’s Syndrome, Diagnosis andTreatment. London, Heinemann, 1972, pp 126–131.

    Google Scholar 

  101. Nelson DH, Meakin JW, Thorn GW: ACTH-producing pituitary tumors of following adrenalectomy for Cushing’s syndrome. Ann Intern Med 52: 560–569, 1960.

    PubMed  CAS  Google Scholar 

  102. Hardy J: Transsphenoidal microsurgery of the normal and pathologic pituitary, Clin Neurosurg 16:185–2l7, 1969.

    CAS  Google Scholar 

  103. Vale W,Spiess J.Rivier C, etal: Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin, and β-eudorpbin.Science 213: 1394–1397, 1981.

    PubMed  CAS  Google Scholar 

  104. Liddle GW. Island D. Meador CR: Normal and abnormal regulation of corticotropin secretion in man. Rec Prog Horm Res 18: 125–126. 1962.

    CAS  Google Scholar 

  105. Samaan NA: Hormone production in non-endocrine tumors. Cancer 273: 148, 1977.

    Google Scholar 

  106. Rees LH,Bloomfield GA,Gilkes JJh,etal: ACTH as a tumor marker. Ann NY Acad Sci 297: 603–620, 1977.

    PubMed  CAS  Google Scholar 

  107. GilbyFD. Rees LH. Bondy PK: Ectopic hormones as markers of responses to therapy in cancer. International Congress Series, No. 375. Amsterdam, Excerpta Medica. 1976, pp 132–138.

    Google Scholar 

  108. Azzopardi JG. Williams ED: Pathology of “nonendocrine” tumors associated with Cushing’s syndrome. Cancer 22: 274–286, 1968.

    PubMed  CAS  Google Scholar 

  109. Besser GM, Edwards CRW: Cushing’s syndrome. 1: 451–490, 1972.

    Google Scholar 

  110. Reeder HJ, Loriaux DL, lipsett MB: Severe osteopenia in young adults associated with Cushing’s syndrome due to micronodular adrenal disease. J Clin Endocrinol 39:1138 1974.

    Google Scholar 

  111. Scott WH Jr,Foster JH,Rhamy RK,et al: Surgical management of adrenocortical tumors with Cushing’s syndrome. Ann Surg 173:892–905, 1971.

    PubMed  Google Scholar 

  112. Liddle GW, Melmon KL: The adrenals.InWilliams RH (ed): Textbook of Endocrinology (ed 5 ). Philadelphia, Saunders, 1974.

    Google Scholar 

  113. Scott WH Jr. Liddle GW, Harris AP, etal: Diagnosis and treatment of Cushing’s syndrome. Ann Surg 155:696–710, 1962.

    Google Scholar 

  114. Freeark RJ, Waldstein SS: Present status of the diagnosis and treatment of Cushing’s syndrome. Surg Clin North Am 49: 179, 1969.

    Google Scholar 

  115. Davies CJ, Joplin GF, Welbourn RB: Surgical management of the ectopic ACTH syndrome. Ann Surg 196: 246–258, 1982.

    PubMed  CAS  Google Scholar 

  116. Crapo L: Cushing’s syndrome: a review of diagnostic tests. Metabolism 28: 955–977, 1979.

    PubMed  CAS  Google Scholar 

  117. Liddle GW: Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 20:1539–1560, 1960.

    PubMed  CAS  Google Scholar 

  118. White FE, White MC, Drury PL, etal: Value of computed tomography of the abdomen and chest in investigation of Cushing’s syndrome. Br Med J 284:770–774, 1982.

    Google Scholar 

  119. Dunnick NR, Schaner EG,Doppman JL, etal: Computed tomography in adrenal tumours. Am J Roentgenol 132:43–46, 1979.

    CAS  Google Scholar 

  120. Muhm JR,Brown LR,Crowe JK,etal: Comparison of whole lung tomography and CT for detecting pulmonary nodules. Am J Roentgenol 131:981–984, 1979.

    Google Scholar 

  121. Sheedy PF II, Stephens DH, Hattery RR, etal: Computed tomography of the pancreas. Radiol Clin North Am 15: 349–366, 1979.

    Google Scholar 

  122. Salassa RM,Laws ER Jr, Carpenter PC, etal: Transsphenoidal removal of pituitary microadenoma in Cushing’s disease. Unpublished data, 1983.

    Google Scholar 

  123. Salassa RM, Laws ER, Carpenter PC, etal: Transsphenoidal removal of pituitary microadenoma in Cushing’;s disease. Mayo Clin Proc 53: 24–20, 1970.

    Google Scholar 

  124. Tyrell JB, Brooks RM, Fitsgerald PA, etal: Cushing’s disease: selective transsphenoidal resection of pituitary microadenomas. N Engl J Med 298:753–758, 1978.

    Google Scholar 

  125. Bigos ST, Somma M, Rasio E, etal: Cushing’s disease: management by transsphenoidal pituitary microsurgery. J Clin Endocrinol Metab 50: 348–354, 1980.

    PubMed  CAS  Google Scholar 

  126. Scott WH, Liddle GW, Mulherin JL, etal: Surgical experience with Cushing’s disease. Ann Surg 185:524–534, 1977.

    PubMed  Google Scholar 

  127. Watson G, van Heerden JA, Grant CS: Adrenal Cushing’s disease. Unpublished data.

    Google Scholar 

  128. Lawrence JH,Tobia CA, Linfoot JA, etal: Heavy-particle therapy in acromegaly and Cushing’s disease. JAMA 235: 307–310, 1976.

    Google Scholar 

  129. Krieger DT, Amorosa L, Linick F: Cyproheptadine-induced remission of Cushiog’s disease. N Engl J Med 293:893–896, 1975.

    PubMed  CAS  Google Scholar 

  130. Lamberts SWJ, Birkenhager JC: Effect of bromocryptine in pituitary dependent Cushing’s syndrome. J Endocrinol 70:315, 1976.

    PubMed  CAS  Google Scholar 

  131. Jeffcoate WJ, Rees LH, Tomlin S, etal: Metyrapone in long-term management of Cushing’s disease. Br Med J 2: 215 – 217, 1977.

    PubMed  CAS  Google Scholar 

  132. Orth DN: Metyrapone is useful only as an adjunctive therapy in Cushing’s disease. Ann Intern Med 89: 128–130, 1978.

    PubMed  CAS  Google Scholar 

  133. Luton JP, Mahoudeau JA, Bonchard PH, etal: Treatment of Cushing’s disease byo’,o’,p’-DDD: survey of 62 cases. N Engl J Med 300: 459–464, 1979.

    PubMed  CAS  Google Scholar 

  134. Hamberger B, Russell CF, van Heerduo JA, etal: Adrenal surgery: trends during the seventies. Am J Surg 144: 523–526, 1982.

    PubMed  CAS  Google Scholar 

  135. American Cancer Society. Cancer Facts and Figures. New York, 1981, p 15.

    Google Scholar 

  136. McGuire WL: An update on estrogen and progesterone receptors in prognosis for primary and advanced breast cancer. InIacobelli S, et al (eds): Hormones and Cancer. New York, Raven Press, 1980, pp 337–343.

    Google Scholar 

  137. Halsted WS: The results of operation for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Johns Hopkins Hosp Rep 4: 1–54, 1894.

    Google Scholar 

  138. Beatson GT: On treatment of inoperable cases in carcinoma of manima: suggestion for new method of treatment with illustrative cases. Lancet 2:104–107, 162–165, 1896.

    Google Scholar 

  139. Huggins C, Bergenstal DM: Inhibition of human mammary and prostatic cancer by adrenallectomy. Cancer Res 12: 134–141, 1952.

    PubMed  CAS  Google Scholar 

  140. Robin TE, Dalton GA: The role of major endocrine ablation. InStall BA (ed): Breast Cancer Management((Early and Late. Chicago, Year Book, 1977,p 147–156.

    Google Scholar 

  141. Santen RJ, Worgul TJ, Lipton A, etal: Aminoglutethimide as treatment of post-menopausal women with advanced breast carcinoma. Ann Intern Med 96: 94–101, 1982.

    PubMed  CAS  Google Scholar 

  142. Manni A, Pearson OH: Anti-estrogen induced remissions in premenopausal women with stage IV breast cancer: effects of ovarian function. Cancer Treat Rep 64: 779–785, 1980.

    PubMed  CAS  Google Scholar 

  143. Pritchard KL, Thompson DB, Myers RE, etal: Tamoxifen therapy in premenopausal patients with metastatic breast cancer. Cancer Treat Rep 64: 787 – 796, 1980.

    PubMed  CAS  Google Scholar 

  144. Greenblatt RB, Colle ML, Makesh VB: Ovarian and adrenal steroid production in the postmenopausal woman. Obstet Gynecol 47: 383–387, 1976.

    PubMed  CAS  Google Scholar 

  145. Judd HL, Barone RM, Laufer LR, etal: In vivo effects of Δ1-testolactone on peripheral aromatization. Cancer Res [Suppl] 42:3345s–3385s, 1982.

    CAS  Google Scholar 

  146. Newsome HH, Brown PW, Terz JJ, etal: Medical adrenalectomy and plasma steroids in advanced breast carcinoma. Surgery 83: 83–89, 1978.

    PubMed  Google Scholar 

  147. Wells SA, Santer RJ, Lipton A, etal: Medical adrenalectomy with aminoglutethimide. Ann Surg 187: 475–484, 1978.

    PubMed  Google Scholar 

  148. Santen RJ, Santner SJ, Tilsen-Mallett N, etal: In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor. Cancer Res [Suppl] 42:3353s–3359s, 1982.

    CAS  Google Scholar 

  149. Huvos AJ, Hajdu SI, Brosfield RD, etal: Adrenal cortical carcinoma: clinicopathologic study of 34 cases. Cancer 25: 354–361, 1970.

    PubMed  CAS  Google Scholar 

  150. Lipsett MB, Hertz R, Ross GT: Clinical and pathologic aspects of adrenocortical carcinoma. Am J Med 35: 374–383, 1963.

    PubMed  CAS  Google Scholar 

  151. McFarlane DA: Cancer of the adrenal cortex: the natural history, prognosis and treatment in a study of 55 cases. Ann R Coll Surg Engl 23: 155–186, 1958.

    Google Scholar 

  152. van Heerden JA, Henley DJ, Grant CS, etal: Adrenal cortical carcinoma. Surgery 94: 926–931, 1983.

    PubMed  Google Scholar 

  153. Richie JR, Gittes RF: Carcinoma of the adrenal cortex. Cancer 45: 1957–1964, 1980.

    PubMed  CAS  Google Scholar 

  154. Steiner PE: Cancer, Race and Geography. Baltimore, Williams & Wilkins, 1954.

    Google Scholar 

  155. Sullivan M, Boileace M, Hodges CV: Adrenal cortical carcinoma. J Urol 120: 660–665, 1978.

    PubMed  CAS  Google Scholar 

  156. Lewinsky BS, Grigor KM, Symington T, etal: The clinical and pathologic features of “non-hormonal” adrenocortical tumors. Cancer 33: 778–790, 1974.

    PubMed  CAS  Google Scholar 

  157. Harrison TS, Gann DS, Edis AJ, Egdahl, RH: Surgical Disorders of the Adrenal Gland. New York, Grune & Stratton, 1975.

    Google Scholar 

  158. Gabrilove JL, Sharma DC, Wotiz HH, etal: Feminizing adrenocortical tumors in the male, a review of 52 cases including a case report. Medicine (Baltimore) 44: 37–79, 1965.

    CAS  Google Scholar 

  159. Cahill PJ, Sukov RJ: Inferior vena caval involvement by adrenal cortical carcinoma. Urology, 10: 604–607; 1977.

    PubMed  CAS  Google Scholar 

  160. Geelhoed GW, Dunnick NR, Doppman JL: Management of intravenous extensions of endocrine tumors and prognosis after surgical treatment. Am J Surg 139: 844–848, 1980.

    PubMed  CAS  Google Scholar 

  161. Didolkar MS, Bescher RA, Elias EG, etal: Natural history of adrenal cortical carcinoma. A clinicopathologic study of 42 patients. Cancer 47: 2153–2161, 1981.

    PubMed  CAS  Google Scholar 

  162. King DR, Rack EE: Adrenal cortical carcinoma: a clinical pathologic study of 49 cases. Cancer 44: 239–244, 1979.

    PubMed  CAS  Google Scholar 

  163. Bradley EL: Primary and adjunctive therapy in carcinoma of the adrenal cortex. Surg Gynecol Obstet 141: 507–511, 1975.

    PubMed  Google Scholar 

  164. Greenberg PH, Marks C: Adrenal cortical carcinoma: a presentation of 22 cases and a review of the literature. Am Surg 44: 81–85, 1978.

    PubMed  CAS  Google Scholar 

  165. Hutter AM, Kayhoe DE: Adrenal cortical carcinoma: results of treatment with op’DDD in 138 patients. Am J Med 41:581–592, 1966.

    PubMed  Google Scholar 

  166. Lubitz JA, Freeman L, Okun R: Mitotane use in inoperable adrenal cortical carcinoma. JAMA 2223: 1109–1112, 1973.

    Google Scholar 

  167. Ostuni JA, Raginsky MS: Metastatic adrenal cortical carcinoma: documented cure with combined chemotherapy. Arch Intern Med 135: 1257–1258, 1975.

    PubMed  CAS  Google Scholar 

  168. Schteingart DE, Motazidi A, Noonan RA, etal: Treatment of adrenal carcinomas. Arch Surg 117: 1142–1146, 1982.

    PubMed  CAS  Google Scholar 

  169. Schteingart DE, Tsao HS, Taylor CI, etal: Sustained remissions of Cushing’s disease with mitotane and pituitary irradiation. Ann Intern Med 92:613–619, 1980.

    PubMed  CAS  Google Scholar 

  170. Cash R, Brough AJ, Cohen MNP, etal: Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial. J Clin Endocrinol Metab 27: 1239–1248, 1967.

    PubMed  CAS  Google Scholar 

  171. Schteingart DE, Cash R, Coon JW: Aminoglutethimide and metastatic adrenal cancer. JAMA 198: 1007–1010, 1966.

    PubMed  CAS  Google Scholar 

  172. Russi S, Blumenthal HT, Gray SH: Small adenomas of the adrenal cortex in hypertension and diabetes. Arch Intern Med 76: 284–291, 1945.

    CAS  Google Scholar 

  173. Dobbie JW: Adrenocortical nodular hyperplasia: The aging adrenal. J Pathol 99: 1–18, 1969.

    PubMed  CAS  Google Scholar 

  174. Prinz RA, Brooks MH, Churchill R, etal: Incidental asymptomatic adrenal masses detected by computed tomographic scanning: is operation required? JAMA 248: 701–704, 1982.

    PubMed  CAS  Google Scholar 

  175. Bertagna C, Orth DN: Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a: single medical center (1951–1978). Am J Med 71: 855–875, 1981.

    PubMed  CAS  Google Scholar 

  176. Smith JM, Keane FB, ’;Flynn JD, etal: Primary non-functioning carcinoma of adrenal cortex. Urology 13: 253–255, 1979.

    PubMed  CAS  Google Scholar 

  177. Young HH: A technique for simultaneous exposure and operation on the adrenals. Surg Gynecol Obstet 54: 179, 1936.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Department of Surgery, Royal Perth Hospital, Victoria Square, Perth, Western Australia

    Anthony J. Edis M.D. (Associate Professor)

  2. Department of Surgery, Mayo Clinic, 55901, Rochester, Minnesota, USA

    Clive S. Grant M.D., Ph.D.

  3. Boston University Medical Center, 720 Harrison Avenue, 02118, Boston, Massachusetts, USA

    Richard H. Egdahl M.D., Ph.D.

Authors
  1. Anthony J. Edis M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Clive S. Grant M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard H. Egdahl M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag New York Inc.

About this chapter

Cite this chapter

Edis, A.J., Grant, C.S., Egdahl, R.H. (1984). Surgery of the Adrenals. In: Manual of Endocrine Surgery. Comprehensive Manuals of Surgical Specialties. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-5222-1_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-5222-1_3

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-9744-4

  • Online ISBN: 978-1-4612-5222-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation